Retrospective Cohort Study
Copyright ©The Author(s) 2018.
World J Transplantation. Sep 10, 2018; 8(5): 178-187
Published online Sep 10, 2018. doi: 10.5500/wjt.v8.i5.178
Table 8 Adverse events after cAMR diagnosis in the 24 mo follow-up (number of total events)
PE-IVIG-RTX group (n = 9)Control group (n = 12)
Infections
Pyelonephritis and urinary tract infections10
Gastrointestinal (diarrhea, ileitis)20
Respiratory infection (bronchiolitis)10
Acute cholecystitis10
Cancers02
Death11

  • Citation: Mella A, Gallo E, Messina M, Caorsi C, Amoroso A, Gontero P, Verri A, Maletta F, Barreca A, Fop F, Biancone L. Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results. World J Transplantation 2018; 8(5): 178-187
  • URL: https://www.wjgnet.com/2220-3230/full/v8/i5/178.htm
  • DOI: https://dx.doi.org/10.5500/wjt.v8.i5.178